AR023479A1 - Formas cristalinas de la sal de sodio de 5-cloro-2-metoxi-n-(2-4-metoxi-3-metilaminotiocarbonilamino sulfonilfenil)etil)benzamida - Google Patents

Formas cristalinas de la sal de sodio de 5-cloro-2-metoxi-n-(2-4-metoxi-3-metilaminotiocarbonilamino sulfonilfenil)etil)benzamida

Info

Publication number
AR023479A1
AR023479A1 ARP000101712A ARP000101712A AR023479A1 AR 023479 A1 AR023479 A1 AR 023479A1 AR P000101712 A ARP000101712 A AR P000101712A AR P000101712 A ARP000101712 A AR P000101712A AR 023479 A1 AR023479 A1 AR 023479A1
Authority
AR
Argentina
Prior art keywords
metoxi
crystalline forms
sulfonylfenyl
methylaminotiocarbonylamine
benzamida
Prior art date
Application number
ARP000101712A
Other languages
English (en)
Original Assignee
Gompel Marie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gompel Marie filed Critical Gompel Marie
Publication of AR023479A1 publication Critical patent/AR023479A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere a las formas cristalinas de la sal de 5-cloro-2-metoxi-N-(2(4-metoxi-3-metilaminotiocarbonilamino sulfonilfenil)etil)benzamida, a los procesos para su preparacion, su uso y preparaciones farmacéuticas que las comprenden.
ARP000101712A 1999-04-16 2000-04-13 Formas cristalinas de la sal de sodio de 5-cloro-2-metoxi-n-(2-4-metoxi-3-metilaminotiocarbonilamino sulfonilfenil)etil)benzamida AR023479A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19917233A DE19917233A1 (de) 1999-04-16 1999-04-16 Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids

Publications (1)

Publication Number Publication Date
AR023479A1 true AR023479A1 (es) 2002-09-04

Family

ID=7904803

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101712A AR023479A1 (es) 1999-04-16 2000-04-13 Formas cristalinas de la sal de sodio de 5-cloro-2-metoxi-n-(2-4-metoxi-3-metilaminotiocarbonilamino sulfonilfenil)etil)benzamida

Country Status (33)

Country Link
US (1) US6723751B1 (es)
EP (2) EP1173418B1 (es)
JP (1) JP4662640B2 (es)
KR (1) KR100700302B1 (es)
CN (1) CN1168712C (es)
AR (1) AR023479A1 (es)
AT (2) ATE311364T1 (es)
AU (1) AU773246B2 (es)
BR (1) BR0010658A (es)
CA (1) CA2370388C (es)
CZ (1) CZ302459B6 (es)
DE (3) DE19917233A1 (es)
DK (1) DK1173418T3 (es)
EE (1) EE04612B1 (es)
ES (1) ES2251996T3 (es)
HK (1) HK1046270B (es)
HR (1) HRP20010744B1 (es)
HU (1) HU229082B1 (es)
IL (2) IL145921A0 (es)
ME (1) MEP55708A (es)
MX (1) MXPA01010275A (es)
MY (1) MY122588A (es)
NO (1) NO327798B1 (es)
NZ (1) NZ514788A (es)
PL (1) PL203809B1 (es)
RS (1) RS50916B (es)
RU (1) RU2235089C2 (es)
SI (1) SI1173418T1 (es)
SK (1) SK287175B6 (es)
TR (2) TR200102993T2 (es)
TW (1) TWI276622B (es)
WO (1) WO2000063167A1 (es)
ZA (1) ZA200108400B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100857759B1 (ko) * 2003-03-17 2008-09-09 니뽄 다바코 산교 가부시키가이샤 Ｃｅｔｐ 억제제의 약제학적 조성물
TWI393560B (zh) * 2003-05-02 2013-04-21 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2098069T3 (es) 1993-02-23 1997-04-16 Hoechst Ag Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y su utilizacion como agentes farmaceuticos.
DE19505397A1 (de) * 1995-02-17 1996-08-22 Hoechst Ag Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
WO2000015204A2 (en) * 1998-09-10 2000-03-23 Aventis Pharma Deutschland Gmbh Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptor blockers

Also Published As

Publication number Publication date
EP1173418B1 (en) 2005-11-30
CN1354744A (zh) 2002-06-19
DE60040811D1 (de) 2008-12-24
HU229082B1 (hu) 2013-07-29
HK1046270B (zh) 2005-03-11
ZA200108400B (en) 2003-04-30
EP1637519A1 (en) 2006-03-22
HUP0200791A2 (hu) 2002-07-29
SK287175B6 (sk) 2010-02-08
DE19917233A1 (de) 2000-10-19
KR20010109355A (ko) 2001-12-08
RU2235089C2 (ru) 2004-08-27
SK14582001A3 (sk) 2002-01-07
BR0010658A (pt) 2002-02-19
MEP55708A (en) 2011-05-10
NO20015014D0 (no) 2001-10-15
TWI276622B (en) 2007-03-21
MY122588A (en) 2006-04-29
HK1046270A1 (en) 2003-01-03
YU72001A (sh) 2004-07-15
ES2251996T3 (es) 2006-05-16
DK1173418T3 (da) 2006-04-10
SI1173418T1 (sl) 2006-02-28
CN1168712C (zh) 2004-09-29
DE60024431D1 (en) 2006-01-05
JP2002542230A (ja) 2002-12-10
NZ514788A (en) 2003-03-28
ATE311364T1 (de) 2005-12-15
TR200501142T2 (tr) 2005-08-22
JP4662640B2 (ja) 2011-03-30
EE200100532A (et) 2002-12-16
TR200102993T2 (tr) 2002-03-21
AU773246B2 (en) 2004-05-20
ATE414059T1 (de) 2008-11-15
CZ302459B6 (cs) 2011-06-01
HRP20010744A2 (en) 2003-04-30
RS50916B (sr) 2010-08-31
KR100700302B1 (ko) 2007-03-29
HUP0200791A3 (en) 2005-04-28
CA2370388C (en) 2009-10-13
DE60024431T2 (de) 2006-07-27
EP1637519B1 (en) 2008-11-12
CZ20013672A3 (cs) 2002-01-16
NO327798B1 (no) 2009-09-28
PL203809B1 (pl) 2009-11-30
EE04612B1 (et) 2006-04-17
US6723751B1 (en) 2004-04-20
MXPA01010275A (es) 2003-07-21
EP1173418A1 (en) 2002-01-23
CA2370388A1 (en) 2000-10-26
WO2000063167A1 (en) 2000-10-26
IL145921A0 (en) 2002-07-25
IL145921A (en) 2006-07-05
HRP20010744B1 (en) 2010-08-31
NO20015014L (no) 2001-10-15
AU4542800A (en) 2000-11-02
PL351245A1 (en) 2003-04-07

Similar Documents

Publication Publication Date Title
MX9100990A (es) Compuesto monohidrato de furoato de mometasona,al procedimiento para su preparacion y a las composiciones farmaceuticas
ES2090713T3 (es) Sales organicas de n,n'-diacetil-cistina.
GT199900102A (es) Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen.
HN2002000319A (es) Benzamida, heteroarilamida y amidas inversas
MX9300298A (es) Conjugados de tioeter y procedimiento para su preparacion
BR0016227A (pt) Derivados de adamantano
BR0111319A (pt) Composto, processo para preparar um composto, uso de um composto, processo para preparar um sal de um composto, e, composto intermediário
ES2157993T3 (es) Benzoilguanidinas, su preparacion y su uso en medicamentos.
AR017205A1 (es) ANILIDAS MIMÉTICAS DE ÁCIDO RETINOICO, PROCESOS PARA PREPARAR DICHOS COMPUESTOS, COMPOSICIONES FARMACÉUTICAS QUE LOS COMPRENDEN, UN PROCESO PARA PREPARAR DICHAS COMPOSICIONES Y EL USO DE DICHOS COMPUESTOS EN LA ELABORACIoN DE MEDICAMENTOS.
GT199700052A (es) Sales metanosulfonatode5-(2-4-(1,2-benzoisotiazol-3-il)-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-onadihidratadas
PA8506301A1 (es) Cristal de 4- carboxamino- 1,2,3,4,- tetrahidroquinolina 2-sustituida
AR012125A1 (es) UNA SAL DE UN COMPUESTO DERIVADO DEL ÁCIDO NAFTIRIDINA CARBOXíLICO , SU USO PARA LA FABRICACIoN DE UN MEDICAMENTO , PROCEDIMIENTO PARA PREPARARLA Y UNA COMPOSICIoN FARMACÉUTICA QUE LO COMPRENDE
NO994671D0 (no) Aryl- eller heteroarylsulfonamid-substituerte hydroksamsyrederivater, fremgangsmaate til fremstillint derav og deres anvendelse som farmasöytika
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
AR014714A1 (es) Sales de cetoacidos y derivados de aminas, y su utilizacion para la preparacion de medicamentos
MX9303572A (es) Inhibidores de proteasa del sindrome de inmunodeficiencia humana, procedimiento para su preparacion y formualcion farmaceutica que los contiene.
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
BR9814495A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo
AR002017A1 (es) Derivados de fenil-4-tiazoles substituidos, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y derivados defenil-4-tiazoles substituidos empleados en dicho procedimiento.
ES2186989T3 (es) Cristales de maltitol de formas especificas, compuestos cristalinos que los contienen y procedimientos para su preparacion.
HN2000000056A (es) Nuevas formas cristalinas de un antibiotico macrolido
AR023479A1 (es) Formas cristalinas de la sal de sodio de 5-cloro-2-metoxi-n-(2-4-metoxi-3-metilaminotiocarbonilamino sulfonilfenil)etil)benzamida
ES2084878T3 (es) Sal colina de diclofenac, un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
ES542061A0 (es) Un procedimiento para la preparacion de (r)-4-amino-n-(1-fe-niletil)benzamida,(s)-4-amino-n-(1-feniletil)benzamida,o unasal de las mismas
AR002978A1 (es) Compuestos benzamidas, composiciones farmacéuticasque los contienen, metodos para preparar los mismos y el uso de los mismos.

Legal Events

Date Code Title Description
FC Refusal